{"disease":{"id":"influenza-human","name":"influenza human"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05858450","title":"This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.","phase":"","overall_status":"COMPLETED","enrollment_count":3442996,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04590066","title":"Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy","phase":"NA","overall_status":"COMPLETED","enrollment_count":734383,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06566534","title":"Personalized Nudging to Increase Influenza Vaccinations","phase":"NA","overall_status":"COMPLETED","enrollment_count":77482,"lead_sponsor_name":"Geisinger Clinic","has_results":false},{"nct_id":"NCT04565353","title":"Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates","phase":"NA","overall_status":"COMPLETED","enrollment_count":74811,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03748160","title":"Herd Immunity and Influenza Vaccine Uptake","phase":"NA","overall_status":"COMPLETED","enrollment_count":48125,"lead_sponsor_name":"Finnish Institute for Health and Welfare","has_results":false},{"nct_id":"NCT05540522","title":"A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":45789,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03278067","title":"Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England","phase":"","overall_status":"COMPLETED","enrollment_count":23939,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07161739","title":"Vaccination Nudges From Pharmacists","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT02893878","title":"Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines","phase":"","overall_status":"COMPLETED","enrollment_count":19334,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06207929","title":"Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections","phase":"","overall_status":"COMPLETED","enrollment_count":18157,"lead_sponsor_name":"Evidation Health","has_results":false},{"nct_id":"NCT04038333","title":"Financing Strategies of Influenza Vaccination in China","phase":"","overall_status":"COMPLETED","enrollment_count":13542,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03239795","title":"Promoting Influenza Vaccination In General Practice Waiting Rooms","phase":"NA","overall_status":"COMPLETED","enrollment_count":10597,"lead_sponsor_name":"Christophe Berkhout","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT06015282","title":"The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7741,"lead_sponsor_name":"Seqirus","has_results":false},{"nct_id":"NCT03332992","title":"Comparative Tests of Flu Vaccination Phone Messages","phase":"NA","overall_status":"COMPLETED","enrollment_count":7206,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT03927131","title":"Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5822,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT03932682","title":"Efficacy Study With QIVc in Pediatric Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5723,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT03165617","title":"Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4514,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT06800950","title":"Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":4400,"lead_sponsor_name":"Institute of Medical Biology, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05514002","title":"Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":3988,"lead_sponsor_name":"Fatimah Dawood","has_results":false},{"nct_id":"NCT04160975","title":"Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects","phase":"NA","overall_status":"COMPLETED","enrollment_count":3245,"lead_sponsor_name":"Harvard University","has_results":true},{"nct_id":"NCT05648448","title":"A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04120194","title":"Phase 3 Pivotal Trial of NanoFlu™ in Older Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2654,"lead_sponsor_name":"Novavax","has_results":true},{"nct_id":"NCT04074928","title":"Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2414,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT02914275","title":"A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2250,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT05044195","title":"A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2044,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT04288921","title":"Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"LumiraDx UK Limited","has_results":false},{"nct_id":"NCT02885246","title":"Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015","phase":"","overall_status":"COMPLETED","enrollment_count":1839,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03314662","title":"Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1778,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT03460743","title":"Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1556,"lead_sponsor_name":"Laboratorios Liomont","has_results":false},{"nct_id":"NCT05110911","title":"Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT02663102","title":"Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.","phase":"","overall_status":"COMPLETED","enrollment_count":1388,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03658629","title":"Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1375,"lead_sponsor_name":"Novavax","has_results":true},{"nct_id":"NCT05779020","title":"Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1373,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT06683352","title":"A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1353,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT05823974","title":"A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1275,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04559204","title":"Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1224,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT06436703","title":"A Study About Modified RNA Vaccines Against Influenza in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1202,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT05052697","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1158,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04790851","title":"Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1133,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT05470582","title":"Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1066,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT03688620","title":"Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1060,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05501561","title":"Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1056,"lead_sponsor_name":"Seqirus","has_results":false},{"nct_id":"NCT05596734","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1019,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT04527614","title":"Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sciensano","has_results":false},{"nct_id":"NCT06382311","title":"A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":991,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04576377","title":"Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":977,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT07204964","title":"A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":971,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04723771","title":"Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020","phase":"","overall_status":"COMPLETED","enrollment_count":949,"lead_sponsor_name":"University of Athens","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}